The wealthy entrepreneur: I want to support millions of employees!.

Chapter 948 Song Mingliang's Surrender! Major Shareholder Shengjin Asia!

Chapter 948 Song Mingliang's Surrender! Major Shareholder Shengjin Asia!

Song Mingliang and Xu Cheng were both willing to help Su Yang acquire Luo Mi. Song Mingliang even explicitly stated that although Su Yaohui didn't say it outright, he definitely agreed to Su Yang's acquisition!
While the two were helping Su Yang come up with ideas, Su Yang also talked about Jufan Holdings and Yuanshi Investment, showing off his strength and financial resources to give Song Mingliang more confidence in him.

He also mentioned that although his group was established not long ago, and many of its subsidiaries were only three years old, some of its general managers already had annual salaries of tens of millions.

There were no general managers with annual salaries of ten million last year, but there definitely will be this year!

Song Mingliang asked curiously, "Is President Su's company a family business?"

He used to have a million-dollar annual salary... but not anymore. He took the lead in cutting his own salary!
"No!" Su Yang shook his head. "I started from scratch!"

"Sigh~"

Song Mingliang felt his scalp tingle. A net worth of over 10 billion in just three or four years—he was truly an exceptional individual!
They could be considered among the best in the country!
"President Su is indeed a self-made man who has made great strides in the catering, online influencer, and finance industries. Everyone in Chongqing knows that!" Xu Cheng said with a smile. "President Song, for you professional managers, it's very important to choose the right boss!"

"Yes!"

Song Mingliang nodded.

After Song Mingliang left, Su Yang thanked Xu Cheng again.

On the way back to the hotel, Yu Chengjun asked curiously, "Boss, are you really going to acquire that company?"

"Ok!"

"That's six hundred million US dollars! More than four billion!"

At the dinner table just now, Yu Chengjun could only try to liven up the atmosphere; otherwise, he couldn't get a word in edgewise.

She had only been by Su Yang's side for a short time, but she found that Su Yang's business deals were getting bigger and bigger!
In the past, we negotiated deals for millions or tens of millions; now we negotiate deals for hundreds of millions or billions!
She suspected that it wouldn't be long before the boss would be negotiating deals worth tens of billions or even hundreds of billions!
"Yes!"

"Boss, do you really have faith in Romi Biotechnology?"

"I'm still quite optimistic!" Su Yang nodded. "At least I'm interested in innovative drugs, and having too much money is a hot potato. Haven't you noticed that more people want to see me lately?"

"That seems to be true!" Yu Chengjun nodded. "Recently, everyone in Rongcheng has been saying that the boss has made over 10 billion yuan in the stock market!"

"Who knows, one day there might be rumors that I've made a hundred billion!" Su Yang said helplessly. "So, it's never wrong for me to spend more money!"

"All right!"

However, having a big reputation isn't without its advantages; at least this investment opportunity was secured thanks to it!
The next day, Cheng Wenhuo led a team to Guangzhou. After hearing that Su Yang wanted to target the innovative drug company, he also contacted several professional medical consultants through his connections.

Once the acquisition is finalized, our professional advisors will come to review the company's R&D technology and various data!

Innovative drug companies often have very high technological barriers to entry, and the company's M&A department lacks professionals capable of evaluating and investigating such companies!
Although Su Yang had great faith in Romi Bio's skills and capabilities, he still needed a medical consultant to take a good look at them; at least they needed to appear quite professional!

After only one day in Guangzhou, as expected, Yuan Yongjun, the person in charge of Shengjin Asia, quickly contacted Su Yang.

This company is the major shareholder of Romi Biotechnology. After hearing from Song Mingliang that Su Yang was interested in Romi and agreed with the company's valuation of $600 million, they took the initiative to contact Su Yang.

They proactively contacted Su Yang, and Su Yang proactively contacted them to acquire the product; naturally, there will be a price difference!
According to Song Mingliang, Shengjin Asia internally hopes to sell off Romi Bio, especially the newly appointed general manager Yuan Yongjun.

After all, if they had confidence in Romi Bio, they wouldn't have let Romi Bio's R&D funding run into such a tight spot. Song Mingliang's words also confirmed Su Yang's thoughts!

Su Yang talked with Yuan Yongjun and said that unless he could acquire the entire company, he would not consider buying shares from any single investment institution.

"Does President Su have a high opinion of Romi Bio?"

Although Yuan Yongjun wanted to sell his shares, his shrewdness as a businessman made him realize how much Su Yang valued Romi Bio.

"It would be a lie to say I'm not optimistic, otherwise I wouldn't have considered spending these billions!" Su Yang said with a smile. "I admire Professor Su, and I'm also interested in anti-cancer drugs!"

Yuan Yongjun agreed, saying, "Professor Su is indeed an outstanding technical leader!"

He didn't have much interaction with Professor Su, but at this moment he definitely had to praise Professor Su... otherwise how could he find an opportunity to raise the price?
If possible, he still wants to sell his shares in RomiBio at a higher price.

"Mr. Yuan, don't even think about raising the price. I'll be frank! I do have money, but acquiring the company and setting aside sufficient R&D funds is quite difficult and will definitely affect the company's cash flow!" Su Yang said very frankly. "Anyway, the valuation is only $600 million. If everyone is willing to sell to me, I'll buy it. If not, then forget it. After all, innovative drugs are still very risky, and Romi Bio has lost its financing ability!"

"All right!"

Faced with such a candid Su Yang, Yuan Yongjun was at a loss for what to do!

They've already made it very clear: they're asking for 600 million. If they don't want to sell, then forget it.

Yuan Yongjun also felt that 600 million was a reasonable price.

It can only be said that these investment companies can make some money, but not much.

It was a very dignified exit!
"This is Cheng Wenhuo, our company's M&A manager. He'll be staying in Guangzhou for a while. If President Yuan is willing to sell, we can talk to him!" Su Yang introduced Cheng Wenhuo and then said, "I have a lot of things to do here, so I can't stay in Guangzhou for long!"

"Okay!" Yuan Yongjun thought for a moment and said, "I'll go back and discuss it with the company!"

"can!"

Using his mind-reading ability and business acumen, Su Yang knew that the matter was probably settled.

After achieving initial success, RomiBio sold its semi-finished drugs for $1.2 billion, but RomiBio was ultimately sold for only $1 billion.

What now?
RomiBio's drug is still under development!
If you're wondering why RomiBio sells for such a low price, it's definitely related to Aisi Medical's payment method.

It's impossible for them to transfer 1.2 billion yuan in cash to RomiBio's account all at once. They must have used a payment method that is a milestone in the innovative drug industry.

This is a payment term in collaborative transactions in the biopharmaceutical field, referring to the phased payments received by the licensor after key milestones such as drug development, clinical research, registration and approval, and commercialization have been achieved.

In other words, the 1.2 billion yuan will be paid in installments, and a significant portion of the money will be used for subsequent research and development. This means that Romi Bio has become an outsourced R&D agency for Aisi.

Upon completion of each phase, Aisi Medical will provide funding for that phase, totaling approximately 1.2 billion yuan!
And right now, Pumi Bio is definitely not worth a valuation of one billion!
Based on the results of business analysis, other investment institutions were ultimately able to accept a valuation of $600 million!

If the price goes down a bit further, the shareholders might be unhappy!
Su Yang could indeed negotiate with them one by one, which would save money, but it would take more time!
If they continue talking for a few more months, Su Yaohui might make a breakthrough.

It would be better to finalize the price quickly and acquire the company, so as to avoid price increases later!
After explaining things to Cheng Wenhuo, Su Yang introduced him to Song Mingliang and Xu Cheng. After saying hello to Xu Cheng, Su Yang prepared to go to Shenzhen!
Even though he's already in Guangzhou, he still wants to visit Shenzhen Jintai Public Fund and see Pei Jiaqi!

It's already December, and the ranking of mutual fund returns is gradually entering its final stage!
(End of this chapter)

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like